Results 241 to 250 of about 592,769 (337)
Atrial fibrillation in end‐stage heart failure: Cellular mechanisms behind CASTLE‐HTx
European Journal of Heart Failure, EarlyView.
Maria Knierim +9 more
wiley +1 more source
In this large multicenter study, AF before LVAD implantation was not associated with increased risks of mortality, bleeding, stroke, or pump thrombosis, but was linked to a higher incidence of late VAs. ABSTRACT Introduction A substantial proportion of patients receiving left ventricular assist devices (LVADs) present with pre‐existing atrial ...
Miloud Cherbi +9 more
wiley +1 more source
Decreased Aortic Elasticity in Noncompaction Cardiomyopathy Compared to Dilated Cardiomyopathy. [PDF]
Tukker M +4 more
europepmc +1 more source
We evaluated the usefulness of remote monitoring for advanced heart failure patients using left‐ventricular assist devices (LVADs) in France. A national, retrospective study on a web application (Satelia) at nine locations was conducted. Specialized remote monitoring could facilitate LVAD follow‐ups and improve outcomes.
Clément Delmas +12 more
wiley +1 more source
Cardiovascular magnetic resonance to differentiate veteran athlete's heart with cavity dilatation and mild dilated cardiomyopathy. [PDF]
Javed W +15 more
europepmc +1 more source
Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
N. Diguet +18 more
semanticscholar +1 more source
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter +8 more
wiley +1 more source
Cardiac Rehabilitation in Advanced Dilated Cardiomyopathy Within a Resource-Limited Setting. [PDF]
Hernández-Gutiérrez KG +7 more
europepmc +1 more source
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj +6 more
wiley +1 more source

